Akira Uehara
President chez TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Fortune : 121 M $ au 31/03/2024
Profil
Actuellement, Akira Uehara est président et directeur représentatif de Taisho Pharmaceutical Holdings Co., Ltd. et président de Taisho Pharmaceutical Co., Ltd. (une filiale de Taisho Pharmaceutical Holdings Co., Ltd.). Dans le passé, il a occupé le poste de président de Taisho Toyama Pharmaceutical Co., Ltd.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
30/09/2023 | 2 143 000 ( 2,52% ) | 121 M $ | 31/03/2024 |
Postes actifs de Akira Uehara
Sociétés | Poste | Début |
---|---|---|
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | President | 03/10/2011 |
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Chairman | 01/04/2009 |
Anciens postes connus de Akira Uehara
Sociétés | Poste | Fin |
---|---|---|
Taisho Toyama Pharmaceutical Co., Ltd.
Taisho Toyama Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Part of Taisho Pharmaceutical Holdings Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd. is a Japanese company that engages in the distribution of prescription drugs. The private company is based in Tokyo, Japan. | President | - |
NEC CORPORATION | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
NEC CORPORATION | Technology Services |
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Health Technology |
Taisho Toyama Pharmaceutical Co., Ltd.
Taisho Toyama Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Part of Taisho Pharmaceutical Holdings Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd. is a Japanese company that engages in the distribution of prescription drugs. The private company is based in Tokyo, Japan. | Distribution Services |